Amalgamated Bank’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5K | Hold |
4,430
| – | – | ﹤0.01% | 2709 |
|
2025
Q1 | $6K | Buy |
4,430
+1,664
| +60% | +$2.25K | ﹤0.01% | 2562 |
|
2024
Q4 | $6K | Hold |
2,766
| – | – | ﹤0.01% | 2636 |
|
2024
Q3 | $8K | Hold |
2,766
| – | – | ﹤0.01% | 2532 |
|
2024
Q2 | $6K | Hold |
2,766
| – | – | ﹤0.01% | 2662 |
|
2024
Q1 | $12K | Sell |
2,766
-4,397
| -61% | -$19.1K | ﹤0.01% | 2341 |
|
2023
Q4 | $23K | Sell |
7,163
-823
| -10% | -$2.64K | ﹤0.01% | 2577 |
|
2023
Q3 | $25K | Hold |
7,986
| – | – | ﹤0.01% | 2534 |
|
2023
Q2 | $40K | Sell |
7,986
-260
| -3% | -$1.3K | ﹤0.01% | 2408 |
|
2023
Q1 | $41K | Sell |
8,246
-1,946
| -19% | -$9.68K | ﹤0.01% | 2376 |
|
2022
Q4 | $64K | Hold |
10,192
| – | – | ﹤0.01% | 2311 |
|
2022
Q3 | $110K | Buy |
10,192
+99
| +1% | +$1.07K | ﹤0.01% | 2108 |
|
2022
Q2 | $115K | Buy |
10,093
+743
| +8% | +$8.47K | ﹤0.01% | 2108 |
|
2022
Q1 | $85K | Sell |
9,350
-736
| -7% | -$6.69K | ﹤0.01% | 2254 |
|
2021
Q4 | $150K | Sell |
10,086
-98
| -1% | -$1.46K | ﹤0.01% | 2011 |
|
2021
Q3 | $262K | Sell |
10,184
-691
| -6% | -$17.8K | ﹤0.01% | 1892 |
|
2021
Q2 | $284K | Buy |
10,875
+3,199
| +42% | +$83.5K | ﹤0.01% | 1912 |
|
2021
Q1 | $271K | Sell |
7,676
-750
| -9% | -$26.5K | 0.01% | 1327 |
|
2020
Q4 | $213K | Buy |
8,426
+46
| +0.5% | +$1.16K | 0.01% | 1418 |
|
2020
Q3 | $316K | Buy |
8,380
+618
| +8% | +$23.3K | 0.01% | 1084 |
|
2020
Q2 | $332K | Buy |
+7,762
| New | +$332K | 0.02% | 1051 |
|